Tetraphase CEO touts troubled antibiotic’s peak sales potential; Copenhagen wants to host the EMA
• Shares of Tetraphase Pharmaceuticals $TTPH have dropped more than 90% off their high and the lead antibiotic failed a Phase III, but CEO Guy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
